Who’s a good doggie? Sniffer dogs might one day be able to screen people for COVID-19 in large crowds. But not when they’re hungry or need a good lie down.
Rigor acadêmico, estilo jornalístico
Todos os artigos de COVID testing
Exibindo 21 - 38 de 38 artigos
How likely are false positives or negatives when you take a PCR test for COVID?
The response to the crisis in India speaks to the complexity of public health decision-making.
Immunity to COVID-19 appears to be generated in different ways in different subgroups of people.
Graphene based COVID tests are quick and robust.
Despite the latest tweaks to border testing rules, the risk of imported infection remains very high. NZ’s wider response needs upgrading —including reducing the large numbers of infected returnees.
The pilot of mass testing people in Liverpool failed to pick up over half of cases, but this isn’t the end of the road for antigen testing.
So, if you have ever tested positive, there is a chance you could contract the virus again. And you could infect other people. You should still take the necessary precautions.
A new review from the Australian Academy of Health and Medical Sciences says managing the pandemic into 2021 will mean persisting with the measures that have made Australia’s response successful so far.
Here’s what you need to know about COVID-19 clearances before travelling.
In September, production of rapid tests really ramped up in the US. But due to low accuracy and massive numbers needed, these tests alone are unlikely to have much of an effect on the pandemic.
As NSW Premier Gladys Berejiklian discovered after continuing to work while awaiting the result of a COVID test, you don’t necessarily get any extra credit for ‘sickness presenteeism’. And rightly so.
After recent suspected COVID-19 cases and with repatriation flights postponed, Samoa takes no chances.
Migrant workers’ families suffer from limited access to pandemic-related health care and loss of income.
Widely adopted in the US when pandemic precautions kept people home, telehealth faces a challenge as insurance coverage changes, right when its popularity had surged.
A new test developed in Australia will reportedly be able to tell us whether someone has a high ‘viral load’. But that doesn’t automatically make them a ‘superspreader’.
With a COVID-19 outbreak in the White House, people are watching the health of President Trump and many others. A doctor explains the possible course for this unpredictable disease.
A new test, which can diagnose COVID-19 in 15 minutes, has been approved by the TGA. But it’s no silver bullet.
Principais colaboradores
-
Professor of Microbiology, The Peter Doherty Institute for Infection and Immunity
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Public Health, University of Sheffield
-
Professor of Disability and Health, Melbourne School of Population and Global Health, The University of Melbourne
-
Director of Paediatrics, Austin Health; NHMRC Practitioner Fellow; Senior Principal Research Fellow, The Florey Institute; Professor of Paediatric Neurology Research, The University of Melbourne
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Professor of Public Health, University of Otago
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Professor, Public Service Research, UNSW Sydney
-
Professor of Public Health, University of Otago
-
Professor and Executive Dean: Engineering, University of Canterbury
-
Clinical specialist Virology, Stellenbosch University
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Professor, Clinical Infectious Diseases, Director, Sydney Institute for Infectious Diseases, University of Sydney
